Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
UCB [BE0003739530/UCB]   
[08/08/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notifications BlackRock, Inc.4 notifications referring to situation on 1, 2, 3 and 6 August 2018Threshold crossed: 5%Latest holding: 5.04%Brussels Belgium, 8 August 2018 – 20:00 CEST – regulated information1. Summary of the notificationsPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 4 transparency... See more
 
UCB [BE0003739530/UCB]   
[03/08/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notifications BlackRock, Inc.2 notifications referring to situation on 30 July and 31 July 2018Threshold crossed: 5%Latest holding: 5.02%Brussels Belgium, 3 August 2018 – 20:00 CEST – regulated informationSummary of the notificationsPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2 transparency... See more
 
UCB [BE0003739530/UCB]   
[26/07/2018]

UCB : UCB Media Room: Half Year Results 2018

UCB Half Year Report 2018:UCB continues its growth pathBrussels Belgium, 26 July 2018 – 7:00 CEST – regulated information –Revenue reached € 2.27 billion: 2%, 6% CER;net sales increased to € 2.15 billion: 5%, 10% CER.Underlying profitability rEBITDA increased to € 794 million: 7%, 12% CERR&D update: romosozumab resubmission in the U.S.Financial outlook for 2018 confirmed: Revenue... See more
 
UCB [BE0003739530/UCB]   
[24/07/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notifications BlackRock, Inc.2 notifications referring to situation on 18 July and 19 July 2018Threshold crossed: 5%Latest holding: 5.00%Brussels Belgium, 24 July 2018 – 20:00 CEST – regulated information1. Summary of the notificationsPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2 transparency... See more
 
UCB [BE0003739530/UCB]   
[13/07/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notificationBrussels Belgium, 13 July 2018 – 20:00 CEST – regulated information1. Summary of the notificationPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification dated 9 July 2018 from BlackRock, Inc. having its registered office at 55 East 52nd Street, New York, NY, 10055,... See more
 
UCB [BE0003739530/UCB]   
[13/07/2018]

UCB : UCB Media Room: BLA Resubmission for Evenity to US FDA

UCB and Amgen Resubmit Biologics Licence Application BLA for EVENITYTM Romosozumab to the U.S. FDABLA Includes Data From Pivotal Phase 3 Studies of More Than 11,000 PatientsBrussels, Belgium and Thousand Oaks, CalifJuly 13, 2018, 07:00 CET – UCB Euronext Brussels: UCB and Amgen NASDAQ:AMGN today announced the resubmission of the Biologics License Application BLA to the U.S. Food and Drug... See more
 
UCB [BE0003739530/UCB]   
[06/07/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notifications BlackRock, Inc.2 notifications referring to situation on 29 June and 2 July 2018Threshold crossed: 5%Latest shareholding: 4,91%Brussels Belgium, 6 July 2018 – 20:00 CEST – regulated information1. Summary of the notificationsPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2... See more
 
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...